Skip to main content
Top
Published in: World Journal of Urology 3/2013

01-06-2013 | Original Article

Urological surgery in patients with hemorrhagic bleeding disorders Hemophilia A, Hemophilia B, von Willebrand disease: a retrospective study with matched pairs analysis

Authors: Sebastian Rogenhofer, Stefan Hauser, Anne Breuer, Guido Fechner, Stefan C. Mueller, Johannes Oldenburg, Georg Goldmann

Published in: World Journal of Urology | Issue 3/2013

Login to get access

Abstract

Purpose

To determine retrospectively the perioperative management and outcome of transurethral prostate/bladder surgery (TURP, TURB) and transrectal prostate biopsy in hemophiliacs.

Methods

Thirty-seven hemophilic patients underwent TURP (12 patients), TURB (13 patients), or transrectal prostate biopsy (12 patients) with proactive hemostaseological management (i.e., factor supply, close meshed hemostaseological analysis). Thirty-seven non-hemophiliac patients served as matched pairs who matched for age, gender, accompanying diseases, and the type of surgical procedure. The resulting pairs were analyzed for duration of surgery, hospital stay, and complications.

Results

Average TURP length in hemophiliacs was 77.92 min, in the matched pairs group TURP 67.08 min (p = 0.487). Mean TURB length in hemophiliacs was 43.46 min versus 35.38 min in controls (p = 0.678). More important, the length of hospital stay was significant longer in the hemophiliacs undergoing TURP compared to non-hemophiliac control group (12.08 days vs. 5.83 days; p < 0.001). In TURB patients, similar results were found (11.15 days hemophiliacs vs. 6.15 controls; p = 0.018). Regarding complications (bleeding, hemorrhage, readmission), no significant difference between the groups was obtained.

Conclusion

Urological interventions in hemophiliac patients with factor supply have the same risk for postoperative complications as in non-hemophiliacs. The only significant difference between hemophiliacs and non-hemophiliacs was the length of hospital stay.
Literature
1.
go back to reference Lee CA, Lillicrap D, Astermark J (2006) Inhibitor development in hemophiliacs: the roles of genetic versus environmental factors. Semin Thromb Hemost 32(Suppl 2):10–14PubMedCrossRef Lee CA, Lillicrap D, Astermark J (2006) Inhibitor development in hemophiliacs: the roles of genetic versus environmental factors. Semin Thromb Hemost 32(Suppl 2):10–14PubMedCrossRef
2.
go back to reference Bolton-Maggs PH, Stobart K, Smyth RL (2004) Evidence-based treatment of haemophilia. Haemophilia 10(Suppl 4):20–24PubMedCrossRef Bolton-Maggs PH, Stobart K, Smyth RL (2004) Evidence-based treatment of haemophilia. Haemophilia 10(Suppl 4):20–24PubMedCrossRef
3.
go back to reference Hoyer LW, Scandella D (1994) Factor VIII inhibitors: structure and function in autoantibody and hemophilia A patients. Semin Hematol 31:1–5PubMed Hoyer LW, Scandella D (1994) Factor VIII inhibitors: structure and function in autoantibody and hemophilia A patients. Semin Hematol 31:1–5PubMed
4.
go back to reference Furie B, Limentani SA, Rosenfield CG (1994) A practical guide to the evaluation and treatment of hemophilia. Blood 84:3–9PubMed Furie B, Limentani SA, Rosenfield CG (1994) A practical guide to the evaluation and treatment of hemophilia. Blood 84:3–9PubMed
5.
go back to reference Craddock CG, Fenninger LD, Simmons B (1948) Hemophilia: problem of surgical intervention for accompanying diseases review of the literature and report of a case. Ann Surg 128:888–903PubMedCrossRef Craddock CG, Fenninger LD, Simmons B (1948) Hemophilia: problem of surgical intervention for accompanying diseases review of the literature and report of a case. Ann Surg 128:888–903PubMedCrossRef
6.
go back to reference Ingerslev J, Hvid I (2006) Surgery in hemophilia. The general view: patient selection, timing, and preoperative assessment. Semin Hematol 43:S23–S26PubMedCrossRef Ingerslev J, Hvid I (2006) Surgery in hemophilia. The general view: patient selection, timing, and preoperative assessment. Semin Hematol 43:S23–S26PubMedCrossRef
7.
go back to reference Rudowski WJ (1981) Moynihan Lecture, 1980. Major surgery in haemophilia. Ann R Coll Surg Engl 63:111–117PubMed Rudowski WJ (1981) Moynihan Lecture, 1980. Major surgery in haemophilia. Ann R Coll Surg Engl 63:111–117PubMed
8.
go back to reference Benoit G, Lambert T, Blanchet P, Laurian Y, Lasjaunias P, D’Oiron R, Eschwege P, Langloys J, Droupy S, Kriaa F, Jardin A (2000) Which urologic treatment alternatives are there for the hemophiliac patient? Prog Urol 10:388–396PubMed Benoit G, Lambert T, Blanchet P, Laurian Y, Lasjaunias P, D’Oiron R, Eschwege P, Langloys J, Droupy S, Kriaa F, Jardin A (2000) Which urologic treatment alternatives are there for the hemophiliac patient? Prog Urol 10:388–396PubMed
9.
go back to reference Goldmann G, Holoborodska Y, Oldenburg J, Schaefer N, Hoeller T, Standop J, Kalff JC, Hirner A, Overhaus M (2010) Perioperative management and outcome of general and abdominal surgery in hemophiliacs. Am J Surg 199(5):702–707PubMedCrossRef Goldmann G, Holoborodska Y, Oldenburg J, Schaefer N, Hoeller T, Standop J, Kalff JC, Hirner A, Overhaus M (2010) Perioperative management and outcome of general and abdominal surgery in hemophiliacs. Am J Surg 199(5):702–707PubMedCrossRef
Metadata
Title
Urological surgery in patients with hemorrhagic bleeding disorders Hemophilia A, Hemophilia B, von Willebrand disease: a retrospective study with matched pairs analysis
Authors
Sebastian Rogenhofer
Stefan Hauser
Anne Breuer
Guido Fechner
Stefan C. Mueller
Johannes Oldenburg
Georg Goldmann
Publication date
01-06-2013
Publisher
Springer-Verlag
Published in
World Journal of Urology / Issue 3/2013
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-012-0988-9

Other articles of this Issue 3/2013

World Journal of Urology 3/2013 Go to the issue